A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis

T Sawicki, M Ruszkowska, A Danielewicz… - Cancers, 2021 - mdpi.com
Simple Summary According to the available data, colorectal cancer (CRC) is one of the most
common malignant neoplasms. Depending on the location, type of cancer or gender, it is …

Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality

S Wang, Y Liu, J Li, L Zhao, W Yan, B Lin… - Frontiers in Cell and …, 2021 - frontiersin.org
Colorectal cancer (CRC) is a common cancer worldwide with complex etiology.
Fusobacterium nucleatum (F. nucleatum), an oral symbiotic bacterium, has been linked with …

Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer

MA Osman, H Neoh, NS Ab Mutalib, SF Chin… - Scientific Reports, 2021 - nature.com
Dysbiosis of the gut microbiome has been associated with the pathogenesis of colorectal
cancer (CRC). We profiled the microbiome of gut mucosal tissues from 18 CRC patients and …

Oral microbiota affects the efficacy and prognosis of radiotherapy for colorectal cancer in mouse models

J Dong, Y Li, H Xiao, S Zhang, B Wang, H Wang, Y Li… - Cell reports, 2021 - cell.com
Radiotherapy is inevitably intertwined with various side effects impairing the quality of life of
cancer patients. Here, we report the possibility that alterations of the oral microbiota …

Faecal microbial biomarkers in early diagnosis of colorectal cancer

CV Olovo, X Huang, X Zheng… - Journal of cellular and …, 2021 - Wiley Online Library
Colorectal cancer (CRC) is ranked as the second most common cause of cancer deaths and
the third most common cancer globally. It has been described as a 'silent disease'which is …

A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the …

S Saber, EE Abd El-Fattah, G Yahya, NA Gobba… - Pharmaceuticals, 2021 - mdpi.com
Inflammasome targeting and controlling dysbiosis are promising therapeutic approaches to
control ulcerative colitis. This report is the first to investigate the mechanisms underlying the …

Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal …

J Veziant, R Villéger, N Barnich, M Bonnet - Cancers, 2021 - mdpi.com
Simple Summary Gut microbiota is emerging as new diagnostic and prognostic marker
and/or therapeutic target to improve the management of cancer. This review aims to …

[HTML][HTML] Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients

YY Hsieh, SY Tung, HY Pan, TS Chang… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND An increased amount of Fusobacterium nucleatum (F. nucleatum) is
frequently detected in the gastric cancer-associated microbiota of the Taiwanese population …

Role of gut microbiota in epigenetic regulation of colorectal Cancer

Y Zhao, C Wang, A Goel - Biochimica et Biophysica Acta (BBA)-Reviews …, 2021 - Elsevier
Colorectal cancer (CRC) remains one of the most commonly diagnosed cancers and a
leading cause of cancer-related deaths worldwide. The stepwise accumulation of epigenetic …

The pathogenic oral–gut–liver axis: new understandings and clinical implications

J Imai, S Kitamoto, N Kamada - Expert review of clinical …, 2021 - Taylor & Francis
Introduction Oral health is closely related to extra-oral disease status, as may be
represented by the manifestations of gastrointestinal and liver diseases. Areas covered This …